Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure

Journal Title: Current Research: Cardiology - Year 2017, Vol 4, Issue 4

Abstract

AIM: The aim was to evaluate clinical, morphological, functional features and mortality in patients with congestive heart failure (CHF) and different time of the best response to cardiac resynchronization therapy (CRT). MATERIALS AND METHODS: 122 patients (82.8% men) with NYHA functional class III-IV (mean age 54.8 ± 9.6 years) were enrolled. At baseline, 1, 3 months and each 6 months after implantation we evaluated clinical and echocardiographic parameters. In 28 patients the best decrease of left ventricular end-systolic volume (LVESV) was achieved up to 3 months (1.1 ± 0.9 months, I group–early response) and in 94 patients–after 3 months (22.6 ± 14.9 months, II group–late response). RESULTS: At baseline groups did not differ in main clinical characteristics, the proportion of atrial fibrillation, the presence of left bundle-branch block (LBBB), width of the QRS complex and parameters of mechanical dyssynchrony. Level of left ventricular ejection fraction (LVEF) and left ventricular volumes were comparable between groups. In the II group responders (decrease in LVESV ≥ 15%) were identified more frequently (90.4% vs. 60.7%; p=0.001), all patients with decrease of LVESV ≥ 30% (super responders) had late response. During follow-up period (33.2 ± 16.7 months) increase in LVEF and decrease in LVESV were more evident in patients with late response. In Kaplan-Meier analysis mortality in II group was significantly lower (3.2% vs 28.6%; p=0.001). Cox regression showed that LVESV (HR 1.012; 95% CI 1.004–1.021; P=0.005) and the time of response (HR 0.131; 95% CI 0.032– 0.530; P=0.004) were associated with long-term mortality. CONCLUSION: Patients with early response to CRT show significantly lower improvement in LVEF and LVESV compared to patients with late CRT response. Super respone to CRT in associated with late functional improvement. Early response and greater LVESV are associated with higher mortality rate.

Authors and Affiliations

Soldatova AM, Kuznetsov VA, Krinochkin DV, Enina TN, Gorodniuk IG

Keywords

Related Articles

Kidney affectation in non-complicated high blood pressure patients

INTRODUCTION: High blood pressure is a very frequent condition that deteriorates the so calls target organs: brain, heart and kidney. Objective: to identify the level of renal affectation in non-complicated hypertensive...

GRACE score also predicts anatomic complexity of coronary artery disease patients presenting with non-STEMI

Acute Coronary Syndromes (ACS) represent the most common cause of death in the western world. We retrospectively screened data of non-STEMI patients admitted to the coronary care unit of a tertiary center between March 2...

A case report of Klinefelter’s syndrome hiding behind pulmonary embolism

Klinefelter’s syndrome, characterized by a karyotype of XXY, is characterized by a series of clinical manifestation such as hypogonadism, small testes, gynecomastia and infertility. This condition promotes hypofribrinoly...

Diagnosis, prognostic significance, and characteristics of new-onset right bundle-branch block in patients with acute myocardial infarction: Protocol for a systematic review and meta-analysis

BACKGROUND: Many studies have shown that patients with acute Myocardial Infarction (AMI) and Bundle Branch Block (BBB) may have a worse prognosis than patients with only acute myocardial infarction. Current guidelines re...

Effect of rosuvastatin on serum levels of vaspin and visfatin in patients with CAD

AIM OF THE STUDY: Investigate the effect of Rosuvastatin on serum level of Vaspin and Visfatin in patients with CAD and determine the association between those adipokines and the severity of CAD. BACKGROUND: Statin trea...

Download PDF file
  • EP ID EP602946
  • DOI -
  • Views 35
  • Downloads 0

How To Cite

Soldatova AM, Kuznetsov VA, Krinochkin DV, Enina TN, Gorodniuk IG (2017). Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure. Current Research: Cardiology, 4(4), 58-60. https://europub.co.uk/articles/-A-602946